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Abstract: A fast and efficient approach was established to identify bacteria possessing the 
potential to biosynthesize phenazines, which are of special interest regarding their 
antimicrobial activities. Sequences of phzE genes, which are part of the phenazine 
biosynthetic pathway, were used to design one universal primer system and to analyze the 
ability of bacteria to produce phenazine. Diverse bacteria from different marine habitats 
and belonging to six major phylogenetic lines were investigated. Bacteria exhibiting phzE 
gene fragments affiliated to Firmicutes, Alpha- and Gammaproteobacteria, and 
Actinobacteria. Thus, these are the first primers for amplifying gene fragments from 
Firmicutes and Alphaproteobacteria. The genetic potential for phenazine production was 
shown for four type strains belonging to the genera Streptomyces and Pseudomonas as well 
as for 13 environmental isolates from marine habitats. For the first time, the genetic ability 
of phenazine biosynthesis was verified by analyzing the metabolite pattern of all  
PCR-positive strains via HPLC-UV/MS. Phenazine production was demonstrated for the type 
strains known to produce endophenazines, 2-hydroxy-phenazine, phenazine-1-carboxylic acid, 
phenazine-1,6-dicarboxylic acid, and chlororaphin as well as for members of marine 
Actinobacteria. Interestingly, a number of unidentified phenazines possibly represent new 
phenazine structures. 
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1. Introduction 
Nature is a profitable source of pharmaceutically active substances covering the whole range of 
biological activities such as antimicrobial, antitumoral, antiparasitic or immunosuppressive [1,2]. 
Various natural products or natural product-derived compounds have been approved as drugs or are 
undergoing clinical evaluation and registration [2,3]. Because the rediscovery rate of already known 
substances in standard screening approaches is high, new strategies are urgently needed. Genetic 
approaches for the detection of secondary metabolite pathways are promising tools for the selection of 
biosynthetically talented microorganisms. So far, main targets in this respect were genes encoding for 
polyketide synthases (PKSs) or non-ribosomal peptide synthetases (NRPSs) [4,5]. By focusing on 
polyketides and non-ribosomal peptides other interesting compound classes such as phenazines have 
been neglected so far. Phenazines of natural or synthetic origin turned out to be good drug candidates 
and therefore are promising secondary metabolites [6]. They are heterocyclic, nitrogenous compounds 
that are substituted at different sites of the core ring system and therefore display a wide range of 
structural derivatives and biological activities. More than 100 biologically active (antibacterial, 
antifungal, antiviral, antitumor) phenazines from natural origin are known to date, synthesized mainly 
by Pseudomonas and Streptomyces species [7]. Phenazines produced by the root-colonizing 
Pseudomonas fluorescens 2–79 and Pseudomonas aureofaciens 30–84 are good examples for 
congeners with promising biological activity, in this case inhibiting several fungal plant pathogens [8]. 
An economically successful phenazine is clofazimine (Lamprene®, Novartis), first described in 1957 
which was established as an antileprosy agent and exerts anti-inflammatory properties in controlling 
erythema nodosum leprosum reactions (Official FDA Drug label) [6] as well as other antimicrobial 
activities [9–11]. Clofazimine is a synthetic phenazine analogue belonging to the riminophenazines, a 
group of compounds which was originally discovered in lichens [12,13]. Another phenazine, 
bis(phenazine-1-carboxamide), acts as a potent cytotoxin and represents an interesting class of dual 
topoisomerase I/II directed anticancer drugs [14]. 
Although principal parts of the phenazine biosynthesis (Figure 1) and their genetics are  
known [15,16], there are still gaps in our knowledge and the phenazine pathway is still  
hypothetical [17]. The function and gene products of phzC, phzE and phzD have been experimentally 
proven. These enzymes catalyze the conversion into 3-deoxy-D-arabino-heptulosonic acid 7-phosphate 
(DAHP), 2-amino-2-deoxyisochorismic acid (ADIC) and trans-2,3-dihydro-3-hydroxyanthranilic acid 
(DHHA) [17–20]. The phenazine core structure is synthesized subsequently by condensation of two 
molecules of 6-amino-5-oxocyclohex-2-ene-1-carboxylic acid [17]. Presumably, PhzF is responsible 
for the isomerization of DHHA [18]. By now, the function of the enzymes PhzA, PhzB and PhzG are 
almost enlightened [19] and their role in the condensation and rearrangement reactions to form PCA is 
demonstrated [17]. According to this information, the design of appropriate oligonucleotide probes and 
primers was possible. Mavrodi et al. (2010) [21] quite recently designed four different pairs of 
oligonucleotides on the basis of the phzF gene of the phenazine biosynthesis and investigated the 
diversity of phenazine producers mainly in soil-dwelling and plant-associated bacteria.  
In particular marine bacteria have attracted our interest to search for promising natural  
products [1,22–26]. Therefore, we have investigated the possible application of a genetic approach for 
the detection of new marine isolates using phzE gene fragments as markers for the ability to produce 
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bioactive phenazines. In contrast to Mavrodi et al. (2010) [21], we wanted to design a more universal 
primer system able to study a wide range of bacterial groups including actinomycetes and 
pseudomonades, in order to detect genes of phenazine production in unidentified new isolates without 
prior performance of a phylogenetic classification. 
Figure 1. Schematic representation of the phenazine biosynthesis pathway. 
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2. Results and Discussion 
The high diversity of microbes and their manifold biosynthetic capabilities offer a great potential 
for novel, bioactive secondary products. Genetic approaches such as the application of primer systems 
for NRPS, PKS or halogenases are efficient methods to select appropriate strains for further  
analyses [27,28]. The screening of bacteria for the presence of phenazine genes significantly adds to 
these selection filters. We report here on a rapid universal genetic system for the discovery of bacteria 
that are able to produce phenazines. The suitability of this PCR based screening approach for the 
identification of phenazine producing bacteria was demonstrated. A gene fragment indispensable for 
phenazine biosynthesis (phzE) served as a template for primer generation. As positive controls the type 
strain of S. cinnamonensis, and three subspecies of Pseudomonas chlororaphis, which are all well 
known producers of phenazines, were included in this study. For control strains several phenazine 
biosynthesis gene sequences were available at the NCBI (e.g., AM384985, HM594285, AF007801). 
Altogether 168 bacterial strains (including the four reference organisms) were examined for the 
presence of phzE. The PCR analysis was complemented by a chemical investigation in order to 
demonstrate the expression of the biosynthesis genes and to confirm the production of phenazines as 
proof of concept. 
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2.1. Design of Oligonucleotides to Search for phzE Phenazine Gene Fragments  
Former investigations were able to associate different steps of the phenazine biosynthetic pathway 
with the corresponding genes, e.g., phzC, phzD, phzE and phzF. The transformation from chorismate to 
2-amino-2-deoxyisochorismic acid (ADIC) is necessary for the formation of the core structure of 
phenazines and is catalyzed by the enzyme PhzE. Thus, PhzE is a key enzyme in phenazine 
biosynthesis and the corresponding gene phzE is suitable for primer design. Sequences from the 
phenazine biosynthetic pathway for Alpha-, Beta- and Gammaproteobacteria, Actinomycetes and 
Firmicutes are available at the homepage of the National Centre for Biotechnology Information 
(NCBI) and known from literature [29,30]. To ensure the inclusion of only true phenazine sequences, 
oligonucleotide primers were constructed only from those genes known to be involved in the 
biosynthesis of corresponding chemical substances. Two conserved sites occurred within the alignment 
of phzE sequences (Figure 2), which had a distance to each other to produce fragments of an 
appropriate length. The degenerated primers phzEf (5‘-GAA GGC GCC AAC TTC GTY ATC AA-3‘) 
and phzEr (5‘-GCC YTC GAT GAA GTA CTC GGT GTG-3‘) were designed to amplify a highly 
conserved stretch of the phzE gene of approximately 450 bp. The comparison of the oligonucleotide 
sequences from designed phzEf and phzEr primers with known phenazine genes verified this stretch as 
highly specific for phzE genes. Because the basic phenazine gene cluster including the phzE gene is 
highly conserved and derivatization of the basic phenazine structure are made at a later stage in the 
biosynthesis, the constructed phzE primers are expected to detect genes of a large variety of different 
phenazine structures and are appropriate to search for unknown bacteria producing novel phenazines. 
Figure 2. Alignment of known phzE gene sequences. Marked blocks served as the basis 
for primer construction. 
 
2.2. Screening for phzE Gene Fragments with the Constructed Primers 
Genes belonging to the phenazine biosynthetic pathway were present in approximately 10% of the 
bacterial strains analyzed. PCR results of 13 (8%) out of 164 bacterial strains and four reference 
organisms were positive in regard to the presence of phzE gene fragments (Figure 3, Tables 1 and 2). 
The investigated bacteria comprised different bacterial phyla, namely Actinobacteria (76), 
Bacteroidetes (2), Firmicutes (28) and Proteobacteria (62) (Table 1).  
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Figure 3. PhzE gene fragment amplification of selected strains. Lane 1 and 10: 1 kb  
DNA-ladder; 2: positive control Pseudomonas chlororaphis subsp. chlororaphis DSM 
50083
T
; 3: negative control (without template DNA); 4, 5, and 6: isolates H253, HB117, 
and LB129, respectively, exhibiting phzE fragments; 7, 8, and 9: isolates HB290, HB147, 
and LB164, respectively, exhibiting nor phzE fragments. 
 
Table 1. Distribution of phzE phenazine genes among major phylogenetic groups and 
phenazine production of cultures (number of strains). 
Phylogenetic group 
Number of strains 
Analyzed 
PCR amplification 
phzE gene positive 
Producing phenazines 
in culture 
Actinobacteria
a 
76 11 11 
Bacteroidetes 2 0 0 
Firmicutes 28 1 0 
Alphaproteobacteria 21 2 0 
Betaproteobacteria 2 0 0 
Gammaproteobacteria
b 
39 3 3 
In total 168 17 14 
a 
including control strain S. cinnamonensis. 
b 
including 3 control P. chlororaphis strains. 
Corresponding gene fragments were detected in 11 strains of Actinobacteria, one strain of 
Firmicutes and two strains of the Alphaproteobacteria. All sequences were similar to known phzE 
gene sequences in a range from 65% similarity (phzE of strain LB151 to phzE of P. chlororaphis, 
AAF17499) to 95% similarity (phzE of strain AB108 to phzE of gene from S. cinnamonensis, 
CAL34110) (Table 2). Regarding the environmental isolates none of the strains within the 
Bacteroidetes, Beta- as well as Gammaproteobacteria could be shown to contain phzE in PCR 
amplification. This was unexpected, because among the 36 gammaproteobacterial isolates 18 
Pseudomonas strains were examined and our PCR approach was performed with primer sequences 
largely based on sequences from Pseudomonas strains known as producers of phenazines [16,31,32]. 
The suitability of our primer set to detect phenazine genes in Pseudomonas species was further 
demonstrated by performing a database search that matched perfectly several phenazine genes, e.g.,  
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P. chlororaphis (L48339), Pseudomonas sp. M18 (FJ494909), P. aeruginosa (FM209186, CP000744, 
CP000438, AE004091, AF005404). Anyhow, a study based on phzF sequences exhibited a hit ratio of 
100% including 51 Pseudomonas strains [21]. Therefore, all 18 pseudomonads from our study 
exhibiting negative results using phzE primers were subjected to a genetic approach with phzF primers. 
While the PCR-amplification of phzE and phzF gene fragments of the control type strains was positive 
(Table 2), amplification of the investigated isolates failed. As an additional control experiment, crude 
extracts of six Pseudomonas strains were analyzed by HPLC-UV/MS. Because of the distinctive 
properties of phenazine UV-absorption spectra the presence of phenazine metabolites was out of 
question. Additionally, for another study all natural products from two of the investigated 
Pseudomonas strains were isolated and chemically identified. No phenazines were detected. We 
conclude that the Pseudomonas strains analyzed in this study lack genes for phenazine production and 
are unable to produce phenazines. In agreement with this, the only known marine phenazine producing 
Pseudomonas species is P. aeruginosa [33–35], synthesizing almost always pyocyanin. In contrast, 
different marine streptomycetes are known for production of variable phenazine structures [9]. 
Streptomyces strains in this study are the most productive group as well. While Brevibacterium, 
Bacillus and Pelagibacter were known as marine phenazine producers [36–38], this is the first time 
that representatives of the genera Micromonospora, Kiloniella and Pseudovibrio were identified as 
marine phenazine producers as well. 
Table 2. Presence of phenazine biosynthesis genes in the strains investigated. Information 
on related type strains (according to 16S rRNA sequences) and sequence similarity of phzE 
genes to known phenazine genes is displayed. Length, similarity and original bearer of the 
genetic information of the phzE PCR products are also included. 
Strain no. Next relative type strain 
and acc.-no.
a
 
Phylum
b
 Sequence 
length
c
 
Related phenazine 
gene, acc.-no.
d
, 
similarity  
and producer 
Strains used as  Positive control    
DSM 1042
T 
Streptomyces cinnamonensis DSM 
1042
T
; DQ462657 
A 127 phzE; CAL34110; 100%;  
S. cinnamonenis 
DSM 6698
T 
Pseudomonas chlororaphis subsp. 
aureofaciens DSM 6698
T
; 
AY509898 
GP 139 phzE: ADP21173; 100% 
P. chlororaphis 
phzF: ADP21174; 100% 
P. chlororaphis 
DSM 19603
T
 Pseudomonas chlororaphis subsp. 
aurantiaca DSM 19603
T
; DQ682655 
GP 137 phzE: ADP21173; 98% 
P. chlororaphis 
phzF: ADP21174 49% 
P. chlororaphis 
DSM 50083
T
 Pseudomonas chlororaphis subsp. 
chlororaphis DSM 50083
T
; Z76673 
GP 125 phzE; AAF17499; 92% 
P. chlororaphis 
phzF: AAF17500; 99% 
P. chlororaphis 
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Table 2. Cont. 
Strain no.  Next relative type strain 
and acc.-no.
a
 
Phylum
b
 Sequence 
length
c
 
Related phenazine 
gene, acc.-no.
d
, 
similarity  
and producer 
Environmental  Isolates    
AB108 Pseudovibrio ascidiaceicola F423
T
; 
AB175663 
AP 144 phzE; CAL34110; 95%;  
S. cinnamonenis 
HB117 Streptomyces fulvorobeus LMG 
19901
T
; AJ781331 
A 141 phzE; AAF17499; 73%;  
P. chlororaphis 
HB122 Streptomyces luridiscabiei S63
T
  
AF361784 
A 141 phzE; AAF17499; 74%;  
P. chlororaphis 
HB202 Streptomyces mediolani LMG 
20093
T
; AJ781354 
A 91 phzE; NP_252903; 84%;  
P. aeruginosa 
HB253 Micromonospora matsumotoense 
IMSNU 22003
T
; AF152109 
A 144 phzB; AAF17496; 67%;  
P. chlororaphis 
HB254 Micromonospora matsumotoense 
IMSNU 22003
T
; AF152109 
A 140 phzE; AAF17499; 73%;  
P. chlororaphis 
HB291 Streptomyces fulvorobeus LMG 
19901
T
; AJ781331 
A 140 phzE; AAF17499; 73%;  
P. chlororaphis 
LB066  Kiloniella laminariae LD81
T
;  
AM749667 
AL 132 phzE; CAL34110; 91%;  
S. cinnamonenis 
LB114 Streptomyces flavogriseus DSM 
40323
T
; AJ494864 
A 141 phzE; AAF17499; 79%;  
P. chlororaphis 
LB129 Streptomyces fimicarius ISP 5322
T
; 
AY999784 
A 145 phzB; AAF17496; 75%;  
P. chlororaphis 
LB150 Streptomyces luridiscabiei S63
T
;  
AF361784 
A 132 phzB; AAF17496; 74%;  
P. chlororaphis 
LB151 Streptomyces griseus ATCC51928
T
; 
AF112160 
A 133 phzE; AAF17499; 65%;  
P. chlororaphis 
a 
NCBI accession number. 
(all sequences were at least 98.5% similar to the corresponding type strain). 
b 
A = Actinobacteria, AP = Alphaproteobacteria, GP = Gammaproteobacteria, F = Firmicutes. 
c 
Given is the number of amino acids. 
d 
NCBI accession number. 
2.3. Detection of Phenazines in the phzE Positive Strains 
To demonstrate the synthesis of phenazines in all phzE positive strains, cultures of these strains 
were extracted and analyzed by HPLC-UV/MS analyses. 14 out of 17 of these strains were able to 
produce one or more substances with molecular masses and UV-spectra similar to known phenazines 
(Table 3, Figure 4a–c). In S. cinnamonensis DSM 1042T the production of endophenazines A–C 
(Figure 5) and phenazine-1,6-dicarboxylic acid [15] could be demonstrated (Figure 3a). The metabolite 
chlororaphin was discovered from Pseudomonas chlororaphis subsp. chlororaphis DSM 50083
T
.  
2-hydroxy-phenazine (Figure 5) and phenazine-1-carboxylic acid were produced by Pseudomonas 
chlororaphis subsp. aureofaciens DSM 6698
T
 and Pseudomonas chlororaphis subsp. aurantiaca DSM 
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19603
T
. In addition, the presence of senacarcin A (strain Streptomyces sp. HB117), saphenyl ester D, 
aestivophoenin C and a derivative thereof (strains Streptomyces sp. HB122 and HB291) as well as 
phencomycin methyl ester and 1-carboxymethyl phenazine from strain Streptomyces sp. LB129 
(Figure 3b) were identified. 
All environmental isolates producing phenazines (6%) were marine Streptomyces sp. or 
Micromonospora sp. strains. Most of these strains produced both known phenazines and phenazines 
which did not show any accordance to a database entry. In total, 22 known phenazines were identified. 
In the case of strain Streptomyces sp. HB202 (Figure 4c), the production of streptophenazines A-H was 
verified using NMR spectroscopic analyses [39]. The large number of Streptomyces strains containing 
phzE genes is in good agreement with previous reports describing streptomycetes as a rich source for 
phenazines [9,15,39,40].  
Table 3. Known and putative novel phenazines from the strains studied. 
Strain no. Next relative type 
strain 
[M
+
] UV absorption 
maxima (nm)
a
  
Dereplication of phenazines 
Strains used as  positive control    
DSM 1042
T 
Streptomyces 
cinnamonensis DSM 1042
T
 
206 
224 
327, 249, 212 
371, 249, 215 
no hit in database 
phenazine-1-carboxylic acid [41] 
  268 375, 256, 223 phenazine-1,6-dicarboxylic acid [15] 
  292 371, 254, 214 endophenazine A [15]
 c
 
  306 387, 269, 211 no hit in database 
  308 372, 249, 212 endophenazine C [15] 
  322 375, 256, 223 endophenazine B [15]
c
 
  336 372, 249, 212 no hit in database 
DSM 6698
T 
Pseudomonas chlororaphis 
subsp. aureofaciens DSM 
6698
T
 
196 
224 
368, 257, 219 
371, 249, 215 
2-hydroxy-phenazine [42]
 
 
phenazine-1-carboxylic acid [41] 
DSM 19603
 T
 Pseudomonas chlororaphis 
subsp. aurantiaca DSM 
19603
T
 
196 
224 
368, 257, 219 
371, 249, 215 
2-hydroxy-phenazine [42]
c
  
phenazine-1-carboxylic acid [41]
c 
DSM 50083
 T
 Pseudomonas chlororaphis 
subsp. chlororaphis DSM 
50083
T
 
223 370, 248, 213  chlororaphin [43] 
Environmental  Isolates    
HB117 Streptomyces fulvorobeus 
LMG 19901
T
 
494 
512 
370(br), 274, 224 
370(br), 275, 230 
Senacarcin A 
saphenyl ester D [29] 
HB122 Streptomyces luridiscabiei 
S63
T
  
492 
496 
376, 275, 235sh 
438sh, 383(br), 276, 
227 
saphenyl ester D [29] 
no hit in database 
  498 419sh, 393-325, 289, 
253sh, 220 
no hit in database 
  508 376, 275, 235sh no hit in database 
  510 430(br), 325, 224 derivative of aestivophoenin C [44] 
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Table 3. Cont. 
Strain no. Next relative type 
strain 
[M
+
] UV absorption 
maxima (nm)
a
  
Dereplication of phenazines 
  512 432(br), 327, 226 aestivophoenin C [44] 
HB202 Streptomyces mediolani 
LMG 20093
T
 
396 368, 364sh, 351sh, 252, 
218 
streptophenazines E [39]
c
 
  410 371, 364sh, 354sh, 252, 
213 
streptophenazines C [39]
 
 
  410 368, 364sh, 351sh. 252, 
218 
streptophenazines D [39]
c
 
  424 367, 363sh, 350sh, 252, 
215 
streptophenazines A [39]
 
 
  424 368, 364sh, 351sh, 252, 
218 
streptophenazines B [39]
c
 
  438 368, 364sh, 353sh, 252, 
215 
streptophenazines F [39]
c
 
  438 368, 363sh, 351sh, 252, 
214 
streptophenazines G [39]
 
 
  440 368, 363sh, 352sh, 252, 
215 
streptophenazines H [39]
 
 
HB253 Micromonospora 
matsumotoense IMSNU 
22003
T
 
260 
465 
566 
458, 302sh, 261, 232 
362sh, 345, 299, 221 
362sh, 345, 299, 221 
no hit in database 
no hit in database 
no hit in database 
HB254 Micromonospora 
matsumotoense IMSNU 
22003
T
 
451 
 
 
361, 343, 352, 301, 223 
 
no hit in database 
 
 
HB291 Streptomyces fulvorobeus 
LMG 19901
T
 
492 
496 
376, 275, 235sh 
438sh, 383(br), 276, 
227 
saphenyl ester D [29] 
no hit in database 
  498 419sh, 393-325, 289, 
253sh, 220 
no hit in database 
  508 376, 275, 235sh no hit in database 
  510 430(br), 325, 224 derivative of aestivophoenin C [44] 
  512 432(br), 327, 226 aestivophoenin C [44] 
LB114 Streptomyces flavogriseus 
DSM 40323
T
 
n.d.
b 
n.d.
b
 
370, 270, 244 
419, 367, 305, 228 
no hit in database 
no hit in database 
LB129 Streptomyces fimicarius ISP 
5322
T
 
296 
238 
366, 249, 214 
366, 249, 214 
phencomycin methyl ester [9] 
1-carboxymethyl phenazine 
LB150 Streptomyces luridiscabiei 
S63
T
 
510 sh401, 378, 274, 227 no hit in database 
LB151 Streptomyces griseus  
ATCC 51928
T
 
510 sh401, 378, 274, 227 no hit in database 
a
 sh, shoulder, br, broad. 
b
 n.d., not detectable. 
c 
substance
 
was isolated by prepHPLC and structure was identified by UV-MS and 
1
H NMR analysis (data 
not shown). 
Mar. Drugs 2011, 9                
 
 
781 
Figure 4. (a) UV/MS-chromatogram (black line: MS; green line: UV at 250 nm) of a 17  
day-old GYM agar plate of strain Streptomyces cinnamonensis DSM 1042
T
. 
Endophenazine A-C, phenazine-1-carboxylic acid, phenazine-1,6-dicarboxylic acid and an 
unknown phenazine substance were detected as well as naphterpin and 
furanonaphthachinon I; (b) UV/MS-chromatogram (black line: MS; green line: UV at  
250 nm) of a 17 day-old GYM agar plate of Streptomyces strain LB129. 1-carboxymethyl 
phenazine and phencomycin methyl ester were detected; (c) UV/MS-chromatogram (black 
line: MS; green line: UV at 250 nm) of a 17 day-old GYM agar plate of strain HB202. 
Different streptophenazines and the aromatic polyketide mayamycin were detected. 
 
 
 
a
  
A 
   
c
   
   
b
B
B 
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Figure 5. Structures of selected phenazines produced by Pseudomonas chlororaphis subsp. 
chlororaphis DSM 50083
T
 and Streptomyces cinnamonensis DSM 1042
T
. 
 
In nine of the culture extracts a total of 13 different substances showed typical phenazine like  
UV-absorption spectra, but gave no hit in the databases concerning UV and mass data. This indicates the 
presence of unidentified and possibly new natural phenazine products which warrant further investigation. 
For some of the identified phenazines interesting biological activities were reported. Senacarcin A 
is known for its activity against Gram-positive bacteria and tumor cell lines [45] and aestivophoenin C 
has antioxidative activity and acts as a neuronal cell protecting substance [44]. Interesting bioactivities 
of phenazines are also known from the marine Streptomyces sp. strain HB202, which produced several 
streptophenazines with activity against Gram-positive bacteria [39]. 
We expect that investigation of other so far unidentified phenazines from marine Actinobacteria is a 
remunerative challenge. Interestingly, phenazines were not detected in culture extracts of phzE positive 
strains of Alphaproteobacteria and Firmicutes. Though, all bacteria containing a phzE phenazine gene 
fragment have the capability to synthesize the phenazine core structure, proof of gene fragments from 
a biosynthetic pathway does not give evidence of the integrity of corresponding gene cluster. 
Additionally, the expression of a gene cluster under conditions used is not warranted. Therefore, it is 
most likely that the cultivation conditions used were not appropriate for the production of some of the 
phenazines and have to be modified for the selected strains by our genetic approach in further studies.  
3. Experimental Section 
3.1. Bacterial Strains and Their Phylogenetic Affiliation 
166 bacterial strains used in this study were of diverse phylogenetic affiliation and were isolated from 
Halichondria panicea (HB strains) [46] and Saccharina latissima (synonym Laminaria saccharina)  
(LB strains) [47] collected at the Kiel Fjord, Germany, and also from different sponges collected from 
the Adriatic Sea near Rovinj, Croatia (AB strains). The strains belong to six different phylogenetic 
groups (Table 1). Additionally, type strains known to produce phenazines were used as positive controls: 
Streptomyces cinnamonensis DSM 1042
T
, Pseudomonas chlororaphis subsp. chlororaphis DSM 50083
T
, 
Pseudomonas chlororaphis subsp. aureofaciens DSM 6698
T
, and Pseudomonas chlororaphis subsp. 
aurantiaca DSM 19603
T
. For S. cinnamonensis DSM 1042
T
 phenazine gene sequences and the 
production of different endophenazines and PCA (phenazine-1-carboxylic acid) have been  
demonstrated [15]. P. chlororaphis subsp. chlororaphis produced chlororaphin [48], P. chlororaphis 
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subsp. aureofaciens and P. chlororaphis subsp. aurantiaca produces 2-hydroxy-phenazine [42] and 
phenazine-1-carboxylic acid [41], respectively. 
For identification of the strains 16S rRNA gene sequence analyses were carried out according to  
Thiel et al. 2007 [49]. Comparison of the 16S rDNA sequences was performed using the EMBL 
nucleotide database available at the European Bioinformatics Institute homepage using the Basic Local 
Alignment Search Tool (nucleotide blast) [50] and the Ribosomal Database Project (RDP) database [51]. 
3.2. Design of Oligonucleotides for Molecular Detection of phzE Phenazine Gene Fragments 
For the primer construction, amino acid sequences and nucleotide sequences of different phzE genes 
were retrieved from the European Bioinformatics Institute homepage and aligned using the program 
CLUSTAL_X [52]. Nucleotide sequences were deduced from amino acid sequences. The alignment 
was analyzed manually. The following phzE sequences were used for primer design: Streptomyces 
cinnamonensis (AM384985/CAL34110/68793…70757; putative 2-amino-2-desoxy-isochorismate 
synthase), Pseudomonas chlororaphis PCL1391 (AF195615/AAF17499/4873…6786;  
phenazine-1-carboxamide), Pseudomonas aeruginosa PAO1 (AF005404/AAC64488/3294…5177; 
pyocyanin), and Pseudomonas aeruginosa PAO1 (AE004091/AAG07601/4716660…4718543/ 
AAG05292/2073555…2075438; phenazine biosynthesis protein PhzE). Primers (Table 4) were 
synthesized by MWG (Ebersbach, Germany). In order to check the specificity of the primers, the 
sequences of phzEf and phzEr were compared with sequences from the EMBL database using the 
Basic Local Alignment Search Tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi). This comparison revealed 
100% identity of the primers with corresponding sites of phenazine biosynthesis genes. Since Ashenafi 
et al. (2008) [53] reported that the anthranilate synthase (SvTrpEG) of Streptomyces venezuelae has a 
high degree of amino acid sequence similarity to the phenazine biosynthetic enzyme PhzE, the 
corresponding nucleotide sequence (AF01267) was compared with the phzE primers using the bl2seq 
tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi). No significant similarity was found indicating that false 
positive results are excluded. 
Table 4. Primers used in this study. 
Primer Sequence Function Ref. 
27f 5‘-GAGTTTGATCCTGGCTCAG-3‘ PCR of the 16S rRNA gene [54]  
1492r 5‘-GGTTACCTTGTTACGACTT-3‘ PCR of the 16S rRNA gene [54]  
534r 5‘-ATTACCGCGGCTGCTGG-3‘ Sequencing of the 16S rRNA gene [55]  
342f 5‘-TACGGGAGGCAGCAG-3‘ sequencing of the 16S rRNA gene [55]  
790f 5‘-GATACCCTGGTAGTCC-3‘ sequencing of the 16S rRNA gene [50]  
phzEf 5‘-GAAGGCGCCAACTTCGTYATCAA-3‘ PCR and sequencing of phzE gene this study 
phzEr 5‘-GCCYTCGATGAAGTACTCGGTGTG-3‘ PCR and sequencing of phzE gene this study 
Ps_up1 5‘-ATCTTCACCCCGGTCAACG-3‘ PCR and sequencing of phzF gene [21] 
Ps_low1 5‘-CCRTAGGCCGGTGAGAAC-3‘ PCR and sequencing of phzF gene [21] 
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3.3. Amplification and Identification of the Phenazine Gene Fragments 
The amplification reactions were carried out in a final volume of 25 µL. Taq DNA Polymerase 
(New England BioLabs, Ipswich, UK; MA, 5 U reaction
−1
) with the ThermoPol Buffer Kit (New 
England BioLabs, Ipswich, UK; MA, USA) was applied. Primers phzEf and phzEr were deployed in a 
10 µM concentration. 1 µL of a preparation containing each deoxynucleoside triphosphate at a 
concentration of  2.5 mM was used. 10 to 50 ng DNA of all strains used in this study was employed  
as template.  
The amplification of the phzF gene sequence of the pseudomonads used in this study was performed 
using puReTaq Ready-To-Go polymerase chain reaction Beads (Amersham Biosciences, Uppsala, 
Sweden) with the primers Ps_up1 and Ps_low1 [21]. Cycler conditions for both PCR experiments were 
as follows: Initial denaturation: 94 °C for 120 s followed by 36 cycles of primer annealing at 54.7 °C 
(phzE) and 57 °C (phzF), respectively, for 60 s; primer extension at 72 °C for 120 s and denaturation at 
94 °C for 60 s. A final extension of 72 °C for 420 s was performed. All PCR reactions were conducted 
in a T1 thermocycler (Whatman Biometra
®
, Göttingen, Germany). Results of the amplifications were 
checked on a 1.5% agarose gel stained with ethidium bromide. DNA sequencing was done according 
to Wiese et al. [47]. The comparison of the phzE and phzF fragments, respectively, was done in the 
EMBL nucleotide database available at the European Bioinformatics Institute homepage using the 
Basic Local Alignment Search Tool (blastx) [50]. 
3.4. Cultivation of phzE Strains 
3.4.1. Cultivation of phzE Positive Strain 
All strains with a positive result for phenazine gene fragments were cultivated for subsequent 
chemical analysis of their cell extracts. They were grown on GYM agar plate (4 g glucose, 4 g yeast 
extract, 4 g malt extract, 2 g CaCO3, 15 g agar, 1 L water, pH 7.2) or MB agar plate (37.4 g Difco 
marine broth, 15 g agar, 1 L water, pH 7.2) at 28 °C for 17 days as well as in 100 mL and 1000 mL 
GYM (4 g glucose, 4 g yeast extract, 4 g malt extract, 1 L water, pH 7.2) or MB medium (37.4 g Difco 
marine broth, 1 L water, pH 7.2) at 28 °C and 120 rpm for seven days. The three P. chlororaphis 
strains were cultivated in 1000 mL King B medium [56] at 28 °C and 120 rpm for 24 h. 
3.4.2. Cultivation of phzE Negative Strains  
All strains with a negative result for phenazine gene fragments were cultivated for subsequent 
chemical analysis of their cell extracts. The precultures were grown on TSB medium agar plates (tryptic 
soy broth[Difco], 12 g/L; NaCl 20 g/L; agar 15 g/L) at 28 °C for 1 day. A 1 cm
2
 piece of the agar plate 
was used for inoculation of the main culture. Main cultures were grown in 100 mL TSB medium (with 
four baffles) and KingB medium [56] at 28 °C and 120 rpm for one, three and six days. 
3.5. Culture Extracts of phzE Positive and Negative Strains 
For 1 L cultures the supernatants were separated from the cell mass pellets by centrifugation at 
4.700 × g for 20 min and extracted separately. Cells were homogenized by addition of 150 mL 96% 
Mar. Drugs 2011, 9                
 
 
785 
EtOH and using Ultra-Turrax (IKA, Staufen, Germany) at 13,000 rpm for 30 s. The extracts were dried 
in vacuo and redissolved in MeOH for further analyses. Supernatants and the other cultures were 
extracted with EtOAc by homogenization with the help of Ultra-Turrax at 16,000 rpm for 30 s, also 
dried in vacuo and redissolved in MeOH for further analyses. 
3.6. Chemical Analysis of phzE Positive and Negative Strains 
Reversed phase HPLC experiments were performed using a C18 column (Phenomenex Onyx 
Monolithic C18, 100 × 3.00 mm) applying an H2O (A)/MeCN (B) gradient with 0.1% HCOOH added 
to both solvents (gradient 0 min 5% B, 4 min 60% B, 6 min 100% B; flow 2 mL/min) on a VWR 
Hitachi Elite LaChrom system coupled to an ESI-ion trap detector (Esquire 4000, Bruker Daltonics). 
Dereplication of substances was realized by comparison of MS and UV data obtained by  
HPLC-UV/MS analyses used data from the Antibase [57] and the Chapman & Hall/CRC Dictionary of 
Natural Products databases [58]. For endophenazines A and B, 2-hydroxy-phenazine and  
phenazine-1-carboxylic acid structure was confirmed by 
1
H NMR analysis. 
3.7. Nucleotide Sequence Accession Numbers 
The nucleotide sequence data reported in the present study were deposited in the GenBank 
nucleotide sequence database under the accession numbers HM460698 (AB049), HM460699 
(AB108), AJ849545 (YIM 90018), AM231308 (YIM 36723), GQ863906 (HB117), GQ863907 
(HB122), GQ863918 (HB202), GQ863921 (HB253), GQ863922 (HB254), GQ863926 (HB291), 
AM749667 (LB066), AM913982 (LB114), AM913952 (LB129), AM913970 (LB150) and AM913971 
(LB151) for 16S rRNA and HM460700-HM460715 for phzE gene fragments.  
4. Conclusions 
In conclusion, the application of the phzE primer system is a useful tool to indicate the presence of 
the phenazine biosynthetic pathway in various groups of bacteria. The proof of concept was shown for 
well known producers of phenazines, but also for marine Streptomyces sp. strain. This approach is 
particularly relevant, because many marine Actinobacteria turned out to be active phenazine producers 
and Streptomyces strains are known to synthesize phenazines with anticancer and/or anti-infective 
activities [59]. The method used in this study offers a promising method to test the ability of producing 
phenazines in new isolates of all kinds of bacteria including marine Actinobacteria. 
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